← Evidence map

ReviewHematology. American Society of Hematology. Education Program2017

How should we sequence and combine novel therapies in CLL?

Matthew S DavidsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2017
2018
2019
2020
2021
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29222277